Could you be at risk of typhoid fever?
Every year there are about 21 million cases of typhoid fever
resulting in
222,000 deaths worldwide
VIVOTIF® is not a treatment
for typhoid fever or its complications, including death.
Search the map to see if your travel
destination could put you at risk.
Areas where there is a risk of typhoid fever
Speak with your healthcare professional about whether vaccination is appropriate for you. Not all vaccinated persons will be fully protected against typhoid fever even after a full course of VIVOTIF. Always follow basic sanitation and food and water precautions whether or not you have been immunized against typhoid.
According to the 2023 Canadian Immunization Guide, a recent Quebec study showed more
than 90% of international travellers who contracted typhoid
fever were visiting friends or family living abroad.
What is typhoid fever?
- Contact with a person carrying typhoid
- Eating uncooked, contaminated foods, such as raw fruit without a peel
- Drinking contaminated water or a drink with contaminated ice
What are the signs and symptoms of typhoid fever?
- Fever
- Headache
- Weakness
- Loss of appetite
- Vomiting
- Stomach pain
- Constipation or diarrhea
- Perforated bowel
- Swelling of the brain
- Death*
even after your symptoms are gone.
*VIVOTIF is not indicated to treat the symptoms or reduce consequences
of typhoid fever, including death.
When is typhoid fever vaccination recommended?
Important safety information
VIVOTIF is an oral vaccine for protection of adults and children older than 5 years against typhoid fever, a disease caused by bacteria called Salmonella enterica serovar Typhi (abbr. S. typhi). The final dose of VIVOTIF should be taken at least 1 week before travelling to an area where there is risk of exposure to S. typhi. Immunization may not be suitable for everyone and can be associated with adverse events. 100% protection cannot be guaranteed. VIVOTIF is not indicated to treat the symptoms or reduce consequences of typhoid fever, including death. The vaccine should not replace standard preventive measures such as handwashing and avoiding potentially contaminated food and water.
The most commonly reported side effects of VIVOTIF during clinical studies were: stomach pain, feeling or being sick (nausea and vomiting), diarrhea, fever, flu-like symptoms, headache, and rash.
Side effects that have been reported very rarely during normal use include skin irritation, rashes, red or lumpy raised rashes, itching and hives, severe allergic reactions with drops of blood pressure and loss of consciousness, weakness, generally feeling unwell, shivering, tiredness, pins and needles, dizziness, and joint and muscle pain.
These symptoms disappear spontaneously within a few days. This is not a complete list of side effects. For any unexpected effects while taking VIVOTIF, contact your healthcare professional.
Learn more about VIVOTIF by consulting the Medication Information. Ask your healthcare professional if VIVOTIF is suitable for you.
